Commercial Moderna builds commercial muscle as new launches loom PharmaphorumModerna expands its commercial team, as the FDA issues a mostly positive briefing document on its seasonal flu shot, due to face an adcomm tomorrow.Read full story pharminent June 17, 2026 (Last updated: June 17, 2026) Pharmaphorum Moderna expands its commercial team, as the FDA issues a mostly positive briefing document on its seasonal flu shot, due to face an adcomm tomorrow. Read full story Post navigation Previous: Altaris to acquire Simulations Plus in $375m all-cash dealNext: Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact Related Stories Commercial Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand pharminent September 14, 2026 Commercial Lilly’s $23B Q2 soars over expectations but Foundayo lags Novo’s rival oral GLP-1 pharminent August 5, 2026 Commercial Leqembi sales grow again after subcutaneous approvals pharminent July 29, 2026